Sunday, October 30, 2016
1:00 p.m. – 5:00 p.m.
The World Federation for the Treatment of Opioid Dependence (WFTOD) was founded during the European Opiate Addiction Treatment Association (EUROPAD) meeting of July 2007 in Ljubljana, Slovenia. All of the member nations, which included the member countries of EUROPAD and all of the member states with AATOD, agreed to a charter for the World Federation.
CHAIRMAN: Icro Maremmani, MD, Santa Chiara University Hospital, Pisa, Italy
INTRODUCTIONS: Michael Rizzi, AATOD International Committee Chair, Cranston, RI
- 1:00 p.m.–1:20 p.m.
Effect of Non-Scheduled Urine Tests among All Students in a Private High School in Las Vegas Miriam Adelson, MD, Dr. Miriam & Sheldon G. Adelson Clinic For Drug Abuse Treatment & Research, Inc., Las Vegas, NV, USA
- 1:20 p.m.–1:40 p.m.
Results of the Opioid Substitution Treatment Programs Assessment in Belarus
Alexei Alexandrov, MD, Minsk regional clinical center “Psychiatry-narcology,” Minsk, Belarus
- 1:40 p.m.–2:00 p.m.
Draft Guiding Principles for Regulations Governing the Use of Agonist Medication in the Treatment of Opioid Dependence
Kevin Journac, MD, Clinique Liberté, Bagneux, France, EU
- 2:00 p.m.–2:20 p.m.
Factors Related to High Methadone Dose Among Patients
Mai Hoai Son, MD, Ho Chi Minh AIDS Center, Ho Chi Minh, Vietnam
- 2:20 p.m.–2:40 p.m.
Educational Intervention for Prevention (from Children to MMT Patients)
Einat Peles, PhD, Adelson Clinic for Drug Abuse Treatment & Research, Tel Aviv, Israel
- 2:40 p.m.–3:00 p.m.
COMPASS Project: Inside and Outside Link for Inmates and Patients Who Inject Drugs with Hepatitis B or C in France
André-Jean Remy, MD, Centre Hospitalier de Perpignan
- 3:00 p.m.–3:20 p.m.
Knowledge about HIV and Risky Behavior Among Methadone Maintenance Treatment Patients
Anat Sason, MMHOS, Adelson Clinic for Drug Abuse, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
- 3:20 p.m.–3:40 p.m.
Sustainable Methadone Maintenance Treatment Program by Integrated Model–Lesson Learned from Two Clinics
Van Tieu, MD, Ho Chi Minh AIDS Center, Ho Chi Minh, Vietnam
- 3:40 p.m–4:00 p.m.
Promoting the Recovery Oriented System of Care in Low Resource Setting: The Case of Vietnam
Hoang Huy Vu, MPH, Substance Abuse and Mental Health Services Administration (SAMHSA), Rockville, MD
- 4:00 p.m.–4:20 p.m.
Psychosocial Determinants in the Treatment of Opioid Use Disorder with Buprenorphine
James E. Phelan, LCSW, Veteran Health Administration, Columbus, Ohio, USA
- 4:20 p.m.–5:00 p.m.
Discussion (Questions & Answers)
Sponsored by the American Association for the Treatment of Opioid Dependence, Inc. (AATOD), EUROPAD, and the World Federation for the Treatment of Opioid Dependence (WFTOD)